Table 2A.
JIA patients treated with MTX | JIA patients treated with MTX/ADA | Healthy controls | Significance (p-value) | |
---|---|---|---|---|
ESR (mm/hour) | 12.00 ± 7.82 | 10.85 ± 6.63 | 8.68 ± 5.88 | 0.295 0.509 0.851 |
CRP (mg/l) | 0.85 ± 1.67 | 1.03 ± 2.13 | 1.09 ± 1.68 | 0.923 0.992 0.957 |
Leukocyte (G/l) | 6.92 ± 2.38 | 7.22 ± 1.47 | 6.77 ± 1.35 | 0.959 0.630 0.846 |
ANC (G/l) | 3.94 ± 1.57 | 3.71 ± 1.03 | 3.69 ± 1.14 | 0.803 0.999 0.814 |
Monocyte (%) | 0.33 ± 0.18 | 0.38 ± 0.12 | 0.33 ± 0.84 | 0.988 0.429 0.392 |
Thrombocyte (G/l) | 304.06 ± 62.47 | 295.04± 58.78 | 302.05 ± 89.23 | 0.996 0.939 0.917 |
Data aremeans ± standard deviation. p1 = MTX and control, p2 = MTX/ADA and control, p3 = MTX and MTX/ADA.